Peptide MGF (5 mg) PeptideSciences
oxyPharma
Cena na zapytanie
Zobacz więcejoxyPharma
Tirzepatide Tirzepatide (5 mg) ZPHC
Cena na zapytanie
Tirzepatide ZPHC 5 mg: An innovative approach to treating type 2 diabetes and weight loss Tirzepatide 5 mg is a unique solution for patients seeking not only to improve blood sugar control, but also to manage body weight. This drug is developed for the treatment of type 2 diabetes and is based on the dual action of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) analogues. Both hormones regulate glucose levels and appetite, making tirzepatide a promising tr
● Niedostępny
1
Tirzepatide is a dual GLP-1/GIP receptor agonist developed for the management of type 2 diabetes and body weight. By combining two complementary incretin mechanisms, it supports both blood glucose control and appetite regulation more effectively than single-pathway therapies. ZPHC's 5 mg vial fits the early-to-mid stage of a standard titration schedule.
Key Benefits
- Improves post-meal and fasting blood glucose control
- Suppresses appetite and increases satiety, supporting gradual weight loss
- Supports cardiovascular health markers relevant to metabolic disease
- Dual hormone mechanism (GLP-1 and GIP) for more comprehensive metabolic support
Opinie (0)
Brak opinii.
Podobne produkty
GHRP peptide 2 (5 mg) Nordex
oxyPharma
Cena na zapytanie
Zobacz więcejHexarelin Peptide (2 mg) CanadaPeptides
oxyPharma
Cena na zapytanie
Zobacz więcejGHRP Peptide 6 (5 mg) Nanox
oxyPharma
Cena na zapytanie
Zobacz więcej